Publication | Closed Access
A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma
10
Citations
11
References
2024
Year
With the very promising clinical activity against r/r PTCL, the results of this study support the further investigation of linperlisib for the treatment of r/r PTCL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1